Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bergshoeff

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Peerj|January 18, 2018
Using underwater video to evaluate the performance of the Fukui trap as a mitigation tool for the invasive European green crab (<i>Carcinus maenas</i>) in Newfoundland, CanadaJonathan A Bergshoeff, Cynthia H McKenzie, Kiley Best, et al.
The Analyst|September 1, 1984
Spectrophotometric determination of ozone in air with indigo disulphonateG Bergshoeff, R W Lanting, J van Ham, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1982
Response to fibrinolytic activity and factor VIII-related antigen to stimulation with desmopressin in hyperlipoproteinemiaE J Brommer, J A Gevers Leuven, M M Barrett-Bergshoeff, et al.
Thrombosis and Haemostasis|February 28, 1984
The inability of propranolol and aspirin to inhibit the response of fibrinolytic activity and factor VIII-antigen to infusion of DDAVPE J Brommer, F H Derkx, M M Barrett-Bergshoeff, et al.
Physical Review Letters|October 1, 2013
Zwei-dreibein gravity: a two-frame-field model of 3D massive gravityEric A Bergshoeff, Sjoerd de Haan, Olaf Hohm, et al.
Thrombosis and Haemostasis|November 19, 1997
Inhibition of mannose receptor-mediated clearance of tissue-type plasminogen activator (t-PA) by dextran: a new explanation for its antithrombotic effectF Noorman, M M Barrett-Bergshoeff, M Bekkers, et al.
The Annals of Pharmacotherapy|March 28, 2003
Ritonavir-enhanced pharmacokinetics of nelfinavir/M8 during rifampin useAlina S Bergshoeff, Tom F W Wolfs, Sibyl P M Geelen, et al.
Arzneimittel-Forschung|March 1, 1988
Pharmacokinetics of antigen and activity of recombinant tissue-type plasminogen activator after infusion in healthy volunteersE Seifried, P Tanswell, D C Rijken, et al.
Thrombosis and Haemostasis|September 6, 2006
Fibrinolytic efficacy of Amediplase, Tenecteplase and scu-PA in different external plasma clot lysis models: sensitivity to the inhibitory action of thrombin activatable fibrinolysis inhibitor (TAFI)Ana H C Guimarães, Marrie M Barrett-Bergshoeff, Marco Criscuoli, et al.
Thrombosis and Haemostasis|October 29, 1982
The use of desmopressin acetate (DDAVP) as a test of the fibrinolytic capacity of patients--analysis of responders and non-respondersE J Brommer, M M Barrett-Bergshoeff, R A Allen, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Peerj|January 18, 2018
Using underwater video to evaluate the performance of the Fukui trap as a mitigation tool for the invasive European green crab (<i>Carcinus maenas</i>) in Newfoundland, CanadaJonathan A Bergshoeff, Cynthia H McKenzie, Kiley Best, et al.
The Analyst|September 1, 1984
Spectrophotometric determination of ozone in air with indigo disulphonateG Bergshoeff, R W Lanting, J van Ham, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1982
Response to fibrinolytic activity and factor VIII-related antigen to stimulation with desmopressin in hyperlipoproteinemiaE J Brommer, J A Gevers Leuven, M M Barrett-Bergshoeff, et al.
Thrombosis and Haemostasis|February 28, 1984
The inability of propranolol and aspirin to inhibit the response of fibrinolytic activity and factor VIII-antigen to infusion of DDAVPE J Brommer, F H Derkx, M M Barrett-Bergshoeff, et al.
Physical Review Letters|October 1, 2013
Zwei-dreibein gravity: a two-frame-field model of 3D massive gravityEric A Bergshoeff, Sjoerd de Haan, Olaf Hohm, et al.
Thrombosis and Haemostasis|November 19, 1997
Inhibition of mannose receptor-mediated clearance of tissue-type plasminogen activator (t-PA) by dextran: a new explanation for its antithrombotic effectF Noorman, M M Barrett-Bergshoeff, M Bekkers, et al.
The Annals of Pharmacotherapy|March 28, 2003
Ritonavir-enhanced pharmacokinetics of nelfinavir/M8 during rifampin useAlina S Bergshoeff, Tom F W Wolfs, Sibyl P M Geelen, et al.
Arzneimittel-Forschung|March 1, 1988
Pharmacokinetics of antigen and activity of recombinant tissue-type plasminogen activator after infusion in healthy volunteersE Seifried, P Tanswell, D C Rijken, et al.
Thrombosis and Haemostasis|September 6, 2006
Fibrinolytic efficacy of Amediplase, Tenecteplase and scu-PA in different external plasma clot lysis models: sensitivity to the inhibitory action of thrombin activatable fibrinolysis inhibitor (TAFI)Ana H C Guimarães, Marrie M Barrett-Bergshoeff, Marco Criscuoli, et al.
Thrombosis and Haemostasis|October 29, 1982
The use of desmopressin acetate (DDAVP) as a test of the fibrinolytic capacity of patients--analysis of responders and non-respondersE J Brommer, M M Barrett-Bergshoeff, R A Allen, et al.
Pageof 6